Why is the Pro Medicus share price bucking the sell-off trend and rising today? - Kalkine Media

October 23, 2023 07:29 PM AEDT | By Team Kalkine Media
Follow us on Google News:

In the realm of ASX technology stocks, the Pro Medicus Limited (ASX: PME) share price stands as a beacon of resilience and performance. Despite a broader market downturn, the health imaging technology company's shares have surged by 1% to reach $78.86 in morning trade. This exceptional performance is particularly noteworthy when compared to the 0.9% decline in the ASX 200 index at the time of writing. 

So, what's driving the Pro Medicus share price to defy market trends? 

Investors are flocking to acquire the company's shares following a significant announcement of yet another contract win. ASX PME has inked a lucrative A$16 million, eight-year contract with South Shore Health in the United States. 

South Shore Health, the largest independent health system in South-eastern Massachusetts, operates the 393-bed South Shore Hospital in Weymouth, Massachusetts, and boasts a workforce of over 5,600 employees. The health system has notable clinical affiliations with academic and cancer centers across Massachusetts, all of which utilize the company's Visage 7 Enterprise Imaging Platform. 

This contract operates on a transactional licensing model and encompasses the full-scale implementation of the company's cloud-engineered Visage 7 platform throughout South Shore Health. This includes Visage 7's Open Archive and Workflow modules, setting up a unified diagnostic imaging platform. Moreover, Visage 7 will facilitate enterprise image distribution that is seamlessly integrated into South Shore Health's electronic health record (EHR). 

The management at Pro Medicus has already initiated the planning for the rollout, based on Visage's proven cloud-based implementation process. The go-live date is targeted for the first or second quarter of the 2024 calendar year. 

Dr. Sam Hupert, CEO of Pro Medicus, highlights the pivotal role of autoscaling in their success. He explains, "Our offering is 'autoscaling' – we have one application that is transaction-based and in the cloud, so clients only pay for what they use, regardless of their size." Dr. Hupert is optimistic about securing more contract wins, particularly for their "full-stack" comprising all three Visage products, including the viewer, workflow, and archive. 

With the Pro Medicus share price soaring 50% over the past 12 months, the company is evidently making significant strides in the health imaging technology sector. It is strengthening its presence in the North American integrated delivery network (IDN) landscape and solidifying its reputation as a standout performer among ASX technology stocks. 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.



Top ASX Listed Companies

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK